These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 8297189

  • 1. Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats.
    Graziano MJ, Dethloff LA, Griffin HE, Pegg DG.
    Arch Int Pharmacodyn Ther; 1993; 324():87-104. PubMed ID: 8297189
    [Abstract] [Full Text] [Related]

  • 2. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H.
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [Abstract] [Full Text] [Related]

  • 3. Renal morphology and function in dogs after treatment with the angiotensin-converting enzyme inhibitor quinapril.
    Susick RL, Dominick MA, Ulloa HM, Pegg DG.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):275-82. PubMed ID: 7511758
    [Abstract] [Full Text] [Related]

  • 4. Renal structure and function in rats after suprapharmacologic doses of quinapril, an angiotensin-converting enzyme inhibitor.
    MacDonald JR, Susick RL, Pegg DG, Dominick MA.
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):282-9. PubMed ID: 1376798
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-converting enzyme inhibition attenuates arterial constrictor responses in experimental hypertension.
    Kähönen M, Mäkynen H, Wu X, Arvola P, Pekki A, Pörsti I.
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1701-9. PubMed ID: 8667241
    [Abstract] [Full Text] [Related]

  • 6. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
    Major TC, Overhiser RW, Taylor DG, Panek RL.
    J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005
    [Abstract] [Full Text] [Related]

  • 7. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
    Bak M, Shalmi M, Petersen JS, Poulsen LB, Christensen S.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):33-40. PubMed ID: 8392557
    [Abstract] [Full Text] [Related]

  • 8. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
    Guron G.
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949
    [Abstract] [Full Text] [Related]

  • 9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of angiotensin-converting enzyme with quinapril (CI-906): investigation of antihypertensive mechanisms in spontaneously hypertensive rats.
    Säynävälammi P, Pörsti I, Nurmi AK, Seppälä E, Metsä-Ketelä T, Tuomisto L, Manninen V, Vapaatalo H.
    J Pharmacol Exp Ther; 1986 Apr; 237(1):246-51. PubMed ID: 3007740
    [Abstract] [Full Text] [Related]

  • 11. In vivo kinetics of indoxyl sulfate in humans and its renal interaction with angiotensin-converting enzyme inhibitor quinapril in rats.
    Fujita T, Ishihara K, Yasuda S, Nakamura T, Maeda M, Kobayashi M, Sahashi K, Ikeda Y, Kumagai Y, Majima M.
    J Pharmacol Exp Ther; 2012 Jun; 341(3):626-33. PubMed ID: 22389425
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O, Flesch M, Schnabel P, Teisman AC, Pinto YM, van Gilst WH, Paul M, Böhm M.
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [Abstract] [Full Text] [Related]

  • 14. Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs.
    Navarro-Cid J, Maeso R, Rodrigo E, Muñoz-García R, Ruilope LM, Lahera V, Cachofeiro V.
    Am J Hypertens; 1996 Nov; 9(11):1077-83. PubMed ID: 8931832
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C, Grima M, Michel B, Barthelmebs M, Imbs JL.
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [Abstract] [Full Text] [Related]

  • 18. Converting enzyme inhibition and renal function of conscious uninephrectomized rats [correction of enzyme].
    MacLaughlin M, Campisi R, Amorena C.
    Acta Physiol Pharmacol Ther Latinoam; 1996 Aug; 46(3):203-8. PubMed ID: 9201321
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of two structurally different angiotensin-converting enzyme inhibitors, captopril and quinapril (CI-906), in rats with one-kidney deoxycorticosterone-salt hypertension.
    Pörsti I, Säynävälammi P, Arvola P, Nurmi AK, Manninen V, Ylitalo P, Vapaatalo H.
    Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):543-6. PubMed ID: 3022083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.